Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Neumora Therapeutics, Inc. | Head of R&D | Common Stock | 403K | $4.83M | $11.98 | Feb 14, 2024 | Direct |
Neumora Therapeutics, Inc. | Head of R&D | Stock Option (Right to Buy) | 100K | Feb 14, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NMRA | Neumora Therapeutics, Inc. | Feb 14, 2024 | 2 | $0 | 4 | Feb 16, 2024 | Head of R&D |
NMRA | Neumora Therapeutics, Inc. | Sep 14, 2023 | 2 | $0 | 4 | Sep 18, 2023 | Head of R&D |
NMRA | Neumora Therapeutics, Inc. | Sep 14, 2023 | 0 | $0 | 3 | Sep 14, 2023 | Head of R&D |